OCX-063 is under clinical development by OccuRx and currently in Phase I for Diabetic Retinopathy. According to GlobalData, Phase I drugs for Diabetic Retinopathy have a 78% phase transition success ...
Keep abreast with the latest news related to Diabetic Retinopathy there are 3171 news items on Diabetic Retinopathy that covers updates, breakthroughs and in-depth reports. We provide you with a ...